SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob mice
about
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob mice
description
im Februar 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 February 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2019
@uk
name
SGLT2 inhibition with empaglif ...... lity in prediabetic ob/ob mice
@en
SGLT2 inhibition with empaglif ...... lity in prediabetic ob/ob mice
@nl
type
label
SGLT2 inhibition with empaglif ...... lity in prediabetic ob/ob mice
@en
SGLT2 inhibition with empaglif ...... lity in prediabetic ob/ob mice
@nl
prefLabel
SGLT2 inhibition with empaglif ...... lity in prediabetic ob/ob mice
@en
SGLT2 inhibition with empaglif ...... lity in prediabetic ob/ob mice
@nl
P2093
P1476
SGLT2 inhibition with empaglif ...... y in prediabetic ob/ob-/- mice
@en
P2093
Ann-Cathrine Jönsson-Rylander
Julia Grönros
Li-Ming Gan
Margareta Behrendt
Sven O Göpel
Tasso Miliotis
Ulrika Dahlqvist
P2888
P356
10.1186/S12933-019-0820-6
P407
P577
2019-02-07T00:00:00Z
P6179
1111989408